There is a new type of hyaluronic acid (HA) facial filler on the market called RHA®, a collaboration between the U.S. company Revance and the Swiss manufacturer Teoxane. MARICE COHN BAND MIAMI HERALD ...
Teoxane today announced the publication in the Aesthetic Surgery Journal of a pivotal randomized, controlled, double-blinded trial evaluating the safety and effectiveness of RHA® 3 for lip ...
Teoxane reinforces its commitment to scientific innovation with the publication of a new study in Plastic and Reconstructive Surgery – Global Open, providing robust preclinical and clinical evidence ...
NEWARK, Calif.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company pioneering new innovations in neuromodulators for aesthetic and therapeutic indications, today ...
NEWARK, Calif.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its investigational ...
- Revance gains access to the growing $1.1B U.S. filler market with three differentiated products, and plans to launch in second quarter 2020 - - Fast-tracks Revance’s commercial organization, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback